Overall, Metformin pharmacological intervention in obese postmenopausal women with insulin resistance was able to modify the patients’ sera and attenuated the effects observed in our study on cell viability and Akt phosphorylation on MCF-7 cells, related to obesity-associated phenotypes. The gene discussed is AKT1; the disease is Insulin resistance.